Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis
- 19 August 2008
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 204 (1-2) , 92-100
- https://doi.org/10.1016/j.jneuroim.2008.07.005
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavirus E1, E2, E6 and E7 DNA vaccineVaccine, 2007
- DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protectionEuropean Journal of Immunology, 2007
- Modulation of Experimental Autoimmune Encephalomyelitis by VLA‐2 BlockadeBrain Pathology, 2007
- The ubiquitin–proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cellsInternational Immunology, 2006
- Molecular mimicry in multiple sclerosisAutoimmunity, 2006
- Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and PeptidesInternational Reviews of Immunology, 2005
- Targeting plasmid‐encoded proteins to the antigen presentation pathwaysImmunological Reviews, 2004
- Ubiquitin-Fused and/or Multiple Early Genes from Cottontail Rabbit Papillomavirus as DNA VaccinesJournal of Virology, 2002
- Combination of Gene Delivery and DNA Vaccination to Protect from and Reverse Th1 Autoimmune Disease via Deviation to the Th2 PathwayImmunity, 2001
- A T Helper Cell 2 (Th2) Immune Response against Non-self Antigens Modifies the Cytokine Profile of Autoimmune T Cells and Protects against Experimental Allergic EncephalomyelitisThe Journal of Experimental Medicine, 1997